Information Provided By:
Fly News Breaks for February 10, 2016
CTIC
Feb 10, 2016 | 09:16 EDT
Ladenburg analyst Robert Hazlett downgraded CTI BioPharma to Neutral saying a full clinical hold challenges pacritinib's future. Piper Jaffay and WallachBeth also downgraded CTI this morning.
News For CTIC From the Last 2 Days
There are no results for your query CTIC